Serious Adverse Drug Effects — Seeing the Trees through the Forest
Author:
- Jerry H. GurwitzJGJerry H. Gurwitz
- 30 March 2006
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 354 (13) , 1413-1415
Abstract
The medical community and the public have been buffeted by a steady stream of news linking the use of widely prescribed medications with serious health risks. The latest in this barrage of unsettling reports is an article by Park-Wyllie et al. that appears elsewhere in this issue of the Journal 1 regarding the association of the fluoroquinolone gatifloxacin with dysglycemia.The authors describe the findings of two population-based, nested case–control studies involving outpatients 66 years of age or older who had received treatment with various broad-spectrum antibiotics. The first study demonstrated a substantial increase in the risk of emergency department treatment . . .Keywords
This publication has 7 references indexed in Scilit:
- Outpatient Gatifloxacin Therapy and Dysglycemia in Older AdultsNew England Journal of Medicine, 2006
- Adherence to Black Box Warnings for Prescription Medications in OutpatientsArchives of internal medicine (1960), 2006
- Reform of Drug Regulation — Beyond an Independent Drug-Safety BoardNew England Journal of Medicine, 2006
- Expert and Consumer Evaluation of Patient Medication Leaflets Provided in U.S. PharmaciesJournal of the American Pharmacists Association, 2005
- Communicating safety information to physicians: an examination of dear doctor lettersPharmacoepidemiology and Drug Safety, 2005
- Population-Based Studies of Adverse Drug EffectsNew England Journal of Medicine, 2003
- Contraindicated Use of CisaprideJAMA, 2000